Scarica l'app Stockscreener
586.67
0.56%
-3.33
Dopo l'orario di chiusura:
586.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$590.00
Aprire:
$587.74
Volume 24 ore:
583.36K
Relative Volume:
0.92
Capitalizzazione di mercato:
$46.28B
Reddito:
$4.45B
Utile/perdita netta:
$1.10B
Rapporto P/E:
43.17
EPS:
13.591
Flusso di cassa netto:
$1.06B
1 W Prestazione:
+4.94%
1M Prestazione:
+2.88%
6M Prestazione:
-8.99%
1 anno Prestazione:
-9.75%
Intervallo 1D:
$583.44
$600.84
Intervallo di 1 settimana:
$560.58
$624.15
Portata 52W:
$518.55
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, NTRA, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
586.67 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
TMO
Thermo Fisher Scientific Inc
|
594.00 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
204.76 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
322.10 | 36.95B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
145.97 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Neutral |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-31 | Aggiornamento | Stifel | Hold → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-08-05 | Reiterato | BTIG Research | Buy |
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
IDEXX Releases 2025 Corporate Responsibility Report Highlighting Innovation and Sustainability Progress - Yahoo Finance
IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals - Business Wire
IDEXX Laboratories Inc (IDXX) Balance Sheet - TradingKey
Here's How IDEXX Laboratories Is Placed Ahead of Q2 Earnings - TradingView
IDEXX Laboratories (IDXX) Looks Attractive on Recurring Revenue and High Customer Retention - Yahoo Finance
IDXX|IDEXX Laboratories Inc|Price:544.320|Chg%:+4.955 - TradingKey
IDEXX Laboratories stock holds firm on recurring diagnostics demand - Ad-hoc-news.de
IDEXX Laboratories, Inc. Revenue Breakdown – NASDAQ:IDXX - TradingView
IDEXX Laboratories stock trades near record levels as diagnostics growth supports valuation - Ad-hoc-news.de
IDEXX Laboratories Inc (IDXX) Income Statement - TradingKey
IDEXX Laboratories Inc (IDXX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IDEXX Laboratories Inc (IDXX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IDEXX Laboratories Inc (IDXX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IDEXX Laboratories, Inc. (IDXX) Stock Price, News, Quote & History - Yahoo! Finance Canada
IDEXX Laboratories Inc (IDXX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IDEXX Laboratories Inc (IDXX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - 富途牛牛
IDXX|IDEXX Laboratories Inc|Price:556.100|Chg%:+11.780 - TradingKey
IDEXX Laboratories stock trades near record levels as recurring diagnostics revenue supports valuati - Ad-hoc-news.de
IDEXX Laboratories Inc (IDXX) Valuation: PE, PB & Fair Value Analysis - TradingKey
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
Idexx Could Feel Chill as Pet Owners Face Rising Cost of Living - Morningstar
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IDEXX stock trades near record territory as recurring diagnostics revenue supports double digit grow - AD HOC NEWS
IDXX: Idexx Laboratories Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
IDEXX Laboratories stock holds steady as earnings metrics shape the outlook - AD HOC NEWS
IDXX|IDEXX Laboratories Inc|Price:539.180|Chg%:-0.185 - TradingKey
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IDEXX Laboratories stock trades near record range as recurring veterinary revenue supports margins - AD HOC NEWS
IDEXX Laboratories stock stays anchored to its diagnostics growth - Ad-hoc-news.de
IDEXX Laboratories, Inc. (IDXX): Investor Outlook Reveals 24.85% Potential Upside in the Diagnostics Sector - DirectorsTalk Interviews
IDEXX Laboratories stock trades near record levels as veterinary diagnostics growth supports valuati - Ad-hoc-news.de
IDEXX Laboratories earnings preview: What to expect - MSN
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
New diagnostic test for kidney injury - DVM360
Global Livestock Monitoring Market to Reach $10.3 Billion by 2030, Driven by Digital Agriculture Transformation - GlobeNewswire Inc.
IDEXX Laboratories stock trades near record levels as companion animal diagnostics drive growth - Ad-hoc-news.de
IDEXX Laboratories (IDXX) Could Be 19% Undervalued After Stifel Flags Better Pet Health Trends - Sahm
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Idexx Laboratories (IDXX) Shows Promising Growth Potential - GuruFocus
Is IDEXX Laboratories Inc (IDXX) a Bargain After 4.2% Drop? GF V - GuruFocus
Why IDEXX Laboratories (IDXX) Stock Is Down Today - Moomoo
Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating - Moomoo
Donald TrumpIDEXX LABS UNSOLICITED Trump Trade on Mar. 23, 2026 - Quiver Quantitative
IDEXX Laboratories stock holds steady as diagnostics demand supports long-term growth - ad-hoc-news.de
IDEXX Laboratories Earnings Preview: What to Expect - Barchart.com
IDEXX Laboratories focuses on diagnostics growth. Investors watch demand trends - ad-hoc-news.de
IDEXX Laboratories extends its diagnostics reach as a key S&P 500 health-tech name - ad-hoc-news.de
IDEXX Laboratories Does Not Need More Vet Visits, But It Needs More Tests Per Visit (IDXX) - Seeking Alpha
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
21.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):